Results 251 to 260 of about 13,264 (267)
Some of the next articles are maybe not open access.
FimH antagonists – solubility vs. permeability
2016Urinary tract infections (UTIs) caused by uropathogenic Escherichia coli (UPEC) are among the most prevalent infections worldwide. Since frequent antibiotic treatment favors the emergence of antibiotic resistance, efficient non-antibiotic strategies are urgently needed.
Pang, Lijuan +9 more
openaire +2 more sources
Organic & Biomolecular Chemistry, 2018
The synthesis of glucosinolate–mannoside glycoconjugates combining both the structural features of a myrosinase substrate and a FimH ligand is described.
G. Cutolo +9 more
openaire +3 more sources
The synthesis of glucosinolate–mannoside glycoconjugates combining both the structural features of a myrosinase substrate and a FimH ligand is described.
G. Cutolo +9 more
openaire +3 more sources
Multivalent calix[4]arene-based mannosylated dendrons as new FimH ligands and inhibitors.
Bioorganic chemistry (Print), 2023A. Palmioli +8 more
semanticscholar +1 more source
Charakterisierung der Zellbindungs- und Internalisierungseigenschaften eines FimH Teilpeptids
Bestimmte pathogene E. coli Spezies verfügen über das Adhäsin FimH, mit dem sie sich sowohl in der Blase als auch im Darm anheften. Im Zuge dessen können sie internalisiert werden und Infektionen wie Harnwegsinfektionen und Colitis auslösen. FimH als Targeter zu nutzen, um Arzneistoffe an die Glykokalyx des Urothels oder der Mukosa des Darms zu binden,openaire +1 more source

